Nifty
Sensex
:
:
8083.80
27590.95
-170.00 (-2.06%)
-674.36 (-2.39%)

IT - Software

Rating :
N/A  (View)

BSE: 538837 | NSE: Not Listed

16.15
0.15 (0.94%)
03-Apr-2020 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  15.90
  •  16.15
  •  15.90
  •  16.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  300
  •  0.05
  •  34.40
  •  14.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 24.71
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 39.19
  • N/A
  • 0.86

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 38.11%
  • 0.57%
  • 48.05%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 13.27%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 26.78
  • 13.59
  • 13.35

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 28.06
  • 19.74
  • 14.44

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.32
  • -1.14
  • 15.18

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 23.63
  • 29.59

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 0.87
  • 0.87

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 14.48
  • 16.55

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Net Sales
8
0
0
5
8
-32%
3
6
-48%
4
4
1%
Expenses
6
0
0
6
5
2%
5
5
-5%
5
4
34%
EBITDA
2
0
0
0
2
-
-1
1
-
-1
1
-
EBIDTM
24%
0%
-6%
29%
-42%
22%
-15%
13%
Other Income
0
0
0
0
1
-44%
0
0
8%
0
0
-75%
Interest
1
0
0
1
1
25%
1
0
42%
0
0
89%
Depreciation
1
0
0
1
1
14%
1
1
50%
1
1
15%
PBT
1
0
0
-2
1
-
-3
0
-
-2
0
-
Tax
0
0
0
0
0
-
-1
0
-
0
0
-
PAT
0
0
0
-1
1
-
-2
0
-
-1
0
-
PATM
5%
0%
-26%
18%
-66%
6%
-34%
-3%
EPS
0.25
0.00
0
-0.90
0.93
-
-1.37
0.25
-
-0.98
-0.10
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
21
26
20
18
17
Net Sales Growth
17%
28%
12%
5%
 
Cost Of Goods Sold
1
2
1
0
0
Gross Profit
20
24
19
18
17
GP Margin
93%
94%
94%
99%
99%
Total Expenditure
22
20
17
15
16
Power & Fuel Cost
-
1
0
0
0
% Of Sales
-
3%
2%
2%
2%
Employee Cost
-
7
5
2
3
% Of Sales
-
28%
25%
10%
16%
Manufacturing Exp.
-
0
0
0
0
% Of Sales
-
0%
0%
0%
0%
General & Admin Exp.
-
10
10
13
12
% Of Sales
-
39%
49%
70%
70%
Selling & Distn. Exp.
-
0
0
0
0
% Of Sales
-
0%
0%
0%
0%
Miscellaneous Exp.
-
0
0
0
0
% Of Sales
-
1%
1%
1%
0%
EBITDA
0
6
3
3
2
EBITDA Margin
-2%
22%
17%
16%
10%
Other Income
1
1
1
1
0
Interest
2
2
2
1
1
Depreciation
4
3
2
1
1
PBT
-5
1
0
1
0
Tax
-1
0
0
0
0
Tax Rate
15%
18%
69%
13%
100%
PAT
-5
1
0
1
0
PAT before Minority Interest
-5
1
0
1
0
Minority Interest
0
0
0
0
0
PAT Margin
-22%
4%
1%
4%
0%
PAT Growth
-369%
909%
-86%
7,700%
 
Unadjusted EPS
-3.00
0.74
0.15
0.82
-0.01

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
32
22
17
4
Share Capital
15
11
9
6
Total Reserves
17
7
3
-2
Non-Current Liabilities
8
10
5
8
Secured Loans
7
7
4
3
Unsecured Loans
0
2
1
6
Long Term Provisions
0
0
0
0
Current Liabilities
21
17
9
8
Trade Payables
2
2
2
3
Other Current Liabilities
11
8
4
2
Short Term Borrowings
7
7
2
2
Short Term Provisions
0
0
0
0
Total Liabilities
61
49
31
20
Net Block
20
19
11
9
Gross Block
30
25
16
12
Accumulated Depreciation
9
7
5
3
Non Current Assets
36
29
17
9
Capital Work in Progress
12
9
5
0
Non Current Investment
0
0
0
0
Long Term Loans & Adv.
4
1
0
1
Other Non Current Assets
0
0
0
0
Current Assets
25
21
14
11
Current Investments
0
0
0
0
Inventories
0
0
0
2
Sundry Debtors
15
16
11
7
Cash & Bank
4
1
0
0
Other Current Assets
6
0
0
0
Short Term Loans & Adv.
5
2
2
1
Net Current Assets
3
3
5
3
Total Assets
61
49
31
20

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
4
6
-6
4
PBT
1
0
1
0
Adjustment
5
4
3
2
Changes in Working Capital
-1
3
-8
3
Cash after chg. in Working capital
6
7
-4
5
Interest Paid
-2
-2
-1
-1
Tax Paid
0
0
0
0
Other Direct Exp. Paid
0
0
0
0
Extra & Other Items
0
0
0
0
Cash From Investing Activity
-8
-14
-9
-4
Net Fixed Assets
-5
-12
-6
Net Investments
0
0
0
Others
-2
-2
-2
Cash from Financing Activity
6
10
15
0
Net Cash Inflow / Outflow
2
1
0
0
Opening Cash & Equivalents
1
0
0
0
Closing Cash & Equivalent
4
1
0
0

Financial Ratios

Standalone /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
21
16
13
6
ROA
2%
0%
3%
0%
ROE
4%
1%
10%
0%
ROCE
8%
7%
11%
10%
Fixed Asset Turnover
1
1
1
1
Receivable days
216
247
186
152
Inventory Days
2
5
28
48
Payable days
58
83
212
225
Cash Conversion Cycle
161
169
2
-25
Total Debt/Equity
1
1
1
3
Interest Cover
2
1
2
1

News Update


  • USFDA concludes audit at Jeevan Scientific Technology’s Bioanalytical facility in Hyderabad
    24th Jan 2020, 15:05 PM

    The auditors started the review on January 20, 2020 and completed on January 24, 2020

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.